Not Yet RecruitingNot Applicable

Indigenous Youth and Young Adults With Diabetes Peer Mentorship Program

40 participantsStarted 2024-09-01

Plain-language summary

The goal of this study is to learn if an Indigenous led peer-mentor program can provide Indigenous youth and young adults with the support needed to improve their distress and improve their diabetes control. Also, we will learn about Indigenous youth and young adults experience with diabetes. * Can a peer-mentoring program reduce diabetes distress among Indigenous youth and young adults with diabetes? * What is it like for Indigenous youth and young adults to be live with diabetes? * Can a peer-mentoring program reduce global distress and improve resilience among Indigenous youth and young adults with diabetes? * Can a peer-mentoring program lead to changes in lifestyle (diet, physical activity, substance use) and diabetes related clinical outcomes among Indigenous youth and young adults with diabetes. Researchers will compare distress, resilience, lifestyles, and diabetes related clinical outcomes before participating in the peer-mentoring program and at 6 and 12 months into the program. Additionally, participants will be asked to share their journey with diabetes through photos throughout the program Participants will: * Be paired with peer-mentors who also have diabetes and they will share their journey with diabetes * Participate in activities (grocery tours, walking clubs, land-based activities, cooking classes) held by peer-mentors * Complete questionnaires on distress, resilience, and lifestyle every 6 months. * Participate in Photovoice workshops to share their stories through pictures.

Who can participate

Age range

10 Years – 29 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age 10-29 years old Clinical diagnosis of diabetes or gestational diabetes Exclusion Criteria: Age \> 29 years old Not at risk of diabetes

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Diabetes Distress

Timeframe: 0,6 and 12 months

Trial details

NCT IDNCT06430203

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-04-01

Contact for this trial

Sahar Fazeli

(438) 860-6079 sahar.fazeli@mcgill.ca

View on ClinicalTrials.gov More Diabetes Mellitus trials